Evaluation of Safety, Immunogenicity, and Preliminary Efficacy of PolyPEPI1018 Vaccine with CDx in Subjects with Metastatic Colorectal Cancer

Medicine & Life Sciences

1. Colorectal Neoplasms 100%
2. Vaccines 84%
3. Safety 51%
4. Veterans 43%
5. Neoplasms 35%
6. Therapeutics 26%
7. Military Health 25%
8. Drug Therapy 24%
9. Cancer Vaccines 20%
10. Immunotherapy 14%
11. Accidental Falls 13%
12. Quality of Life 10%
13. United States Department of Veterans Affairs 10%
14. Survivorship 10%
15. Neoplasm Antigens 8%
16. Health Behavior 8%
17. Feeding Behavior 8%
18. Routine Diagnostic Tests 7%
19. Early Diagnosis 6%
20. Cause of Death 6%
21. Immune System 6%
22. Population 6%
23. Comorbidity 6%
24. Patient Care 6%
25. Smoking 6%
26. Clinical Trials 5%
27. Delivery of Health Care 5%
28. Equipment and Supplies 5%